Reproductive Considerations for Transgender Patients

Reproductive Considerations for Transgender Patients

Reproductive Considerations for Transgender Patients

On this page

Intro & GAHT Impact - Fertility Foundations First

  • Transgender Man (TM): Individual assigned female at birth (AFAB) who identifies as a man.
  • Transgender Woman (TW): Individual assigned male at birth (AMAB) who identifies as a woman.
  • Gender-Affirming Hormone Therapy (GAHT): Medical intervention using hormones to align physical characteristics with an individual’s gender identity.
  • GAHT Impact on Fertility:
    • Testosterone (for TM): Can lead to anovulation, ovarian stromal thickening, and endometrial atrophy.
    • Estrogen & Anti-androgens (for TW): May cause impaired spermatogenesis, testicular atrophy, and ↓ semen volume.
  • Crucial Point: Fertility preservation options must be discussed before starting GAHT. 📌 Preserve Potential Progeny Prior (PPPP).

⭐ Effects of GAHT on gametes may not be fully reversible even after cessation; counsel thoroughly about fertility implications before treatment initiation is paramount for informed consent and future family planning options for transgender individuals seeking medical transition services.

Transmasculine Options - Oocytes & Choices

Fertility preservation (FP) should be discussed before starting testosterone (T). If already on T, temporary cessation may be needed.

  • Oocyte Cryopreservation (Egg Freezing):
    • Mature oocytes retrieved after ovarian stimulation (typically 10-14 days).
    • Most established method for individuals without a current partner providing sperm.
  • Embryo Cryopreservation:
    • Oocytes fertilized with sperm (partner/donor) in vitro; embryos frozen.
    • Higher post-thaw survival rates than oocytes historically, but oocyte vitrification has improved.
  • Ovarian Tissue Cryopreservation (OTC):
    • Experimental; involves surgical removal of ovarian tissue.
    • Option for prepubertal individuals or when stimulation is contraindicated.

Considerations with Testosterone:

  • Testosterone can suppress ovarian function; duration of T use may impact oocyte yield/quality.
  • Resumption of menses after T cessation varies (avg. 3-6 months).

⭐ Ovarian stimulation for oocyte retrieval can often be completed within 2-3 weeks after temporarily stopping testosterone, allowing for timely gender-affirming medical treatment.

Loading diagram…

Transfeminine Options - Sperm Savvy Strategies

  • 📌 Key Fertility Strategies (Remember "Four S"):
    • Sperm Banking (Cryopreservation):
      • Optimal: Pre-GAHT initiation. Best quality/quantity.
      • Method: Semen sample collection.
    • Stop GAHT (Attempt Recovery if on hormones):
      • GAHT (Estrogen ± Anti-androgens) suppresses spermatogenesis.
      • Temporary cessation for 3-6+ months (up to 12-24 months).
      • Recovery variable; success ↓ with prolonged GAHT.
    • Surgical Sperm Retrieval (if azoospermic post-cessation):
      • Options: Testicular Sperm Extraction (TESE), Micro-TESE (for non-obstructive azoospermia).
    • Stem Cell Research (Experimental):
      • Testicular tissue cryopreservation for future use.

⭐ Sperm cryopreservation before initiating GAHT offers the best fertility preservation outcomes for transfeminine individuals.

Loading diagram…

Parenthood & Prevention - Babies & Barriers

  • Pregnancy in Transgender Men (TM)
    • Conception: Intercourse, Assisted Reproductive Technology (ART). Testosterone (T) cessation vital; menses typically resume in 2-6 months.
    • Antenatal Care: Standard, with attention to chest binding comfort, hormone monitoring (estradiol, T).
    • Delivery: Individualised (vaginal/cesarean).
    • Chestfeeding: Possible if breast tissue present; T cessation required. Induced lactation an option.
  • Parenthood for Transgender Women (TW)
    • Methods: Using cryopreserved sperm (IVF, IUI with partner/surrogate), adoption, co-parenting.
  • Contraception
    • Essential for all sexually active individuals with reproductive capacity if pregnancy not desired, regardless of Gender-Affirming Hormone Therapy (GAHT).
    • Options: Barrier methods, hormonal contraception (consider interactions), IUDs.

    ⭐ Testosterone therapy in TM does NOT reliably prevent ovulation or pregnancy.

High‑Yield Points - ⚡ Biggest Takeaways

  • Fertility preservation counseling is crucial prior to gender-affirming hormone therapy (GAHT) or surgical interventions.
  • GAHT has potential gonadotoxic effects, which may be irreversible, impacting future fertility.
  • Transmen (AFAB) options include oocyte or embryo cryopreservation before hysterectomy/oophorectomy.
  • Transwomen (AMAB) should consider sperm cryopreservation before GAHT or orchiectomy.
  • Pregnancy is achievable for transmen with a uterus after discontinuing testosterone.
  • Testosterone in transmen suppresses ovulation but is not a reliable contraceptive; discuss contraception.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Reproductive Considerations for Transgender Patients

  1. 1. Which serum level is increased in premature ovarian failure?

    • A. Serum Inhibin
    • B. Serum Estradiol
    • C. Serum Follitropin
    • D. Serum Progesterone
    Show answer

    Answer: C. Serum Follitropin

    Serum Follitropin - FSH rises when ovarian estrogen and inhibin production falls, because reduced negative feedback allows increased pituitary gonadotropin secretion. - In premature ovarian failure, the pituitary attempts to stimulate non-responsive ovaries, producing persistently elevated serum FSH. Serum Inhibin - Inhibin is produced by ovarian granulosa cells and normally suppresses pituitary FSH secretion through negative feedback. - With premature ovarian failure, ovarian dysfunction reduces inhibin production; therefore, serum inhibin is typically decreased rather than increased. Serum Progesterone - Progesterone is produced mainly by the corpus luteum after ovulation, so its level depends on functional ovulatory cycles. - Because premature ovarian failure commonly causes impaired or absent ovulation, serum progesterone is low or undetectable rather than increased. Serum Estradiol - Estradiol is the principal estrogen produced by the ovaries and normally contributes to negative feedback on pituitary gonadotropin secretion. - In premature ovarian failure, impaired ovarian function reduces estradiol production, so serum estradiol is decreased rather than increased.

  2. 2. A 2-year-old boy has constipation and delayed developmental milestones. Examination shows bradycardia and hypotonia. Thyroid function tests show elevated TSH and low free T4. What is the most likely diagnosis?

    • A. Primary hypothyroidism
    • B. Complete hypopituitarism
    • C. Nonsecretory pituitary tumor
    • D. Thyroid hormone resistance
    Show answer

    Answer: A. Primary hypothyroidism

    Primary hypothyroidism - Elevated TSH with low free T4 confirms primary hypothyroidism, reflecting thyroid gland failure with compensatory pituitary stimulation. - Bradycardia, hypotonia, constipation, and developmental delay are characteristic consequences of reduced thyroid hormone, including impaired metabolism and neurodevelopment. Complete hypopituitarism - Complete hypopituitarism can cause growth failure, hypoglycemia, and secondary hypothyroidism, but it would generally produce low or inappropriately normal TSH. - The child instead has elevated TSH, indicating primary thyroid failure rather than deficient pituitary stimulation; therefore, complete hypopituitarism does not fit. Nonsecretory pituitary tumor - A nonsecretory pituitary tumor mainly causes mass effects, such as headache and visual-field defects, or compresses pituitary tissue to cause hypopituitarism. - It would not explain the elevated TSH and low free T4 pattern, which indicates primary hypothyroidism rather than a pituitary mass. Thyroid hormone resistance - Thyroid hormone resistance usually produces elevated free T4 with nonsuppressed TSH, not the low free T4 and hypothyroid phenotype described here.

  3. 3. Hyperpigmentation is seen with which hormone?

    • A. Follicle-stimulating hormone
    • B. Thyroid-stimulating hormone
    • C. Adrenocorticotropic hormone
    • D. Luteinizing hormone
    Show answer

    Answer: C. Adrenocorticotropic hormone

    Adrenocorticotropic hormone - In Addison disease, reduced cortisol removes negative feedback, causing increased ACTH secretion from the pituitary. - ACTH derives from POMC, which also produces α-MSH-related melanocytic activity; excess ACTH can therefore cause hyperpigmentation of skin folds, buccal mucosa, and pressure points. Luteinizing hormone - LH primarily triggers ovulation in females and stimulates testosterone production in males, rather than directly affecting melanocyte activity. - Elevated LH is not characteristically associated with hyperpigmentation; increased ACTH is the relevant hormonal finding in primary adrenal insufficiency. Follicle-stimulating hormone - FSH promotes ovarian follicle development and stimulates spermatogenesis in the testes, with no direct melanocyte-stimulating role. - Increased FSH is therefore not a typical cause of hyperpigmentation; this finding instead reflects increased ACTH activity. Thyroid-stimulating hormone - TSH stimulates the thyroid gland to produce T3 and T4, rather than directly stimulating melanocytes. - Although thyroid disease may alter skin texture or moisture, elevated TSH is not characteristically linked to hyperpigmentation.

  4. 4. What does spermiogenesis refer to?

    • A. Formation of spermatozoa from spermatids
    • B. Formation of secondary spermatocytes from primary spermatocytes
    • C. Formation of spermatids from spermatocytes
    • D. Formation of spermatozoa from spermatogonia
    Show answer

    Answer: A. Formation of spermatozoa from spermatids

    Formation of spermatozoa from spermatids - Spermiogenesis is the final stage of spermatogenesis, transforming a round spermatid into a mature spermatozoon. - It involves formation of the acrosome, nuclear condensation, flagellum development, and shedding of excess cytoplasm. Formation of secondary spermatocytes from primary spermatocytes - This describes meiosis I, during which a primary spermatocyte divides to form two secondary spermatocytes. - Although chromosome number is reduced by half, this division does not produce the morphological transformation characteristic of spermiogenesis. Formation of spermatids from spermatocytes - This describes meiosis II, in which secondary spermatocytes divide to produce spermatids. - The resulting spermatids still require substantial morphological changes before becoming mature spermatozoa. Formation of spermatozoa from spermatogonia - Formation of spermatozoa from spermatogonia describes the complete process of spermatogenesis, including mitosis, meiosis, and spermiogenesis. - It states the overall outcome but does not specifically identify the final transformation of spermatids into spermatozoa.

  5. 5. Which natural family planning method identifies the postovulatory infertile phase from a progesterone-mediated physiological change?

    • A. Complete sexual abstinence method
    • B. Basal body temperature method
    • C. Calendar-based safe period method
    • D. Pre-ejaculatory withdrawal method
    Show answer

    Answer: B. Basal body temperature method

    Basal body temperature method - The BBT method tracks a woman’s daily resting temperature, which typically rises slightly by about 0.5–1.0°F after ovulation. - The sustained temperature rise retrospectively supports recognition that ovulation has occurred and helps identify the subsequent infertile phase; it does not predict the beginning of the preovulatory fertile window. Complete sexual abstinence method - Abstinence prevents pregnancy by completely avoiding sexual intercourse, rather than by monitoring a physiological sign of fertility. - It does not involve basal body temperature tracking, which is the defining feature asked about in this question. Calendar-based safe period method - The safe period method estimates fertility from the typical length and timing of menstrual cycles, rather than measuring body temperature. - Also called the calendar or rhythm method, it uses calculated ovulation timing to identify days when intercourse should be avoided. Pre-ejaculatory withdrawal method - Coitus interruptus involves withdrawing the penis before ejaculation, so it does not require monitoring basal body temperature. - Withdrawal has a relatively higher failure rate, partly because pre-ejaculatory fluid may contain sperm and withdrawal may be mistimed.

  6. 6. Hormone Replacement Therapy (HRT) in postmenopausal women is beneficial in all these except

    • A. Vaginal atrophy
    • B. Osteoporosis
    • C. Vasomotor symptoms
    • D. CAD prevention
    Show answer

    Answer: D. CAD prevention

    CAD prevention - HRT is not recommended for primary CAD prevention; large studies such as the WHI did not demonstrate cardioprotection and showed possible cardiovascular harm. - Potential stroke and venous thromboembolism risks, particularly when therapy begins later after menopause, outweigh any proposed CAD-prevention benefit. Vasomotor symptoms - Vasomotor symptoms such as hot flashes and night sweats result from estrogen-related disruption of thermoregulatory control during menopause. - Systemic HRT is the most effective treatment because estrogen stabilizes thermoregulation and substantially reduces these symptoms. Osteoporosis - Postmenopausal estrogen deficiency accelerates bone resorption, reducing bone mineral density and increasing osteoporosis and fracture risk. - Estrogen-containing HRT inhibits bone resorption and can prevent or treat osteoporosis, so this is a recognized benefit. Vaginal atrophy - Reduced estrogen causes thinning, dryness, and inflammation of vaginal tissues, producing vaginal atrophy and symptoms such as dyspareunia. - Local or systemic estrogen therapy restores vaginal tissue health and improves dryness, irritation, and discomfort.

  7. 7. Tolvaptan is used for:-

    • A. Inappropriate ADH secretion
    • B. Von Willebrand disease
    • C. Central diabetes insipidus
    • D. Catecholamine resistant Shock
    Show answer

    Answer: A. Inappropriate ADH secretion

    Inappropriate ADH secretion - Tolvaptan is a selective vasopressin V2-receptor antagonist that promotes free-water excretion, correcting dilutional hyponatremia in SIADH. - In SIADH, excessive ADH causes water retention and euvolemic hyponatremia; blocking V2 receptors directly counteracts this mechanism. Von Willebrand disease - Von Willebrand disease is caused by deficient or dysfunctional von Willebrand factor and is treated with desmopressin or factor replacement. - Tolvaptan has no role in coagulation or control of mucosal bleeding because it acts on renal vasopressin receptors. Central diabetes insipidus - Central diabetes insipidus results from deficient ADH production, causing excessive free-water loss and polyuria, rather than inappropriate water retention. - Treatment requires desmopressin, a synthetic ADH analogue; tolvaptan blocks ADH action and would worsen the underlying water-loss problem. Catecholamine resistant Shock - In catecholamine-resistant shock, persistent hypotension requires support of vascular tone, commonly with vasopressin or corticosteroids rather than a renal aquaretic. - Tolvaptan promotes water excretion, which can aggravate volume depletion and hypotension, so it has no therapeutic role in this setting.

  8. 8. All are steps of GIFT, except:

    • A. In vitro fertilization
    • B. Intratubal transfer of gametes
    • C. Ovarian stimulation
    • D. Oocyte retrieval
    Show answer

    Answer: A. In vitro fertilization

    In vitro fertilization - GIFT transfers eggs and sperm into the fallopian tube, where fertilization occurs naturally within the woman’s body rather than in a laboratory. - Laboratory fertilization is the defining step of IVF, making it the exception among the listed GIFT procedures. Oocyte retrieval - Mature oocytes are retrieved from the ovaries after stimulation, typically using transvaginal ultrasound-guided aspiration. - Retrieved oocytes are subsequently combined with sperm and transferred into the fallopian tube, so oocyte retrieval is part of GIFT. Intratubal transfer of gametes - GIFT involves transferring unfertilized oocytes together with sperm into the fallopian tube, allowing fertilization to occur naturally in vivo. - This distinguishes GIFT from IVF, in which fertilization occurs in the laboratory before embryos are transferred. Ovarian stimulation - Controlled ovarian hyperstimulation is performed before GIFT to produce multiple mature follicles and increase the number of available oocytes. - This stimulation supports subsequent oocyte retrieval and transfer, making ovulation stimulation an expected GIFT step rather than the exception.

  9. 9. A 5-year-old girl is referred for vaginal bleeding. Physical examination shows breast development, multiple cystic changes in bone radiologically and following skin finding. What is the most likely pubertal disorder?

    • A. Central precocious puberty
    • B. Precocious pseudopuberty
    • C. Premature adrenarche
    • D. Premature thelarche
    Show answer

    Answer: B. Precocious pseudopuberty

    Precocious pseudopuberty - Precocious pseudopuberty is caused by autonomous sex-hormone production without premature hypothalamic-pituitary-gonadal axis activation. - The combination of vaginal bleeding, breast development, fibrous dysplasia, and irregular café-au-lait spots is characteristic of McCune-Albright syndrome. Central precocious puberty - Central precocious puberty results from premature hypothalamic-pituitary-gonadal axis activation, causing pulsatile GnRH secretion and elevated gonadotropins. - Although it can cause breast development and vaginal bleeding, it does not explain the combination of fibrous dysplasia and café-au-lait spots. Premature adrenarche - Premature adrenarche causes early pubic or axillary hair and body odour from adrenal androgen production; it does not explain breast development and vaginal bleeding. Premature thelarche - Premature thelarche causes isolated breast development without vaginal bleeding, other pubertal signs, or significant bone-age advancement. - It does not account for fibrous dysplasia or café-au-lait spots, which instead suggest McCune-Albright syndrome with peripheral hormone production.

  10. 10. What is the most distinctive functional characteristic of the barrier method shown?

    • A. Greater efficacy than male condoms
    • B. Insertion immediately after coitus
    • C. Protection against sexually transmitted infections
    • D. Extended vaginal retention
    Show answer

    Answer: D. Extended vaginal retention

    Extended vaginal retention - The contraceptive sponge can be inserted up to 24 hours before intercourse and retained for multiple acts, providing continuous protection during that period. - It must remain for at least 6 hours after the last intercourse but not exceed 30 hours total, making extended vaginal retention its distinctive functional feature. Protection against sexually transmitted infections - The contraceptive sponge does not protect against sexually transmitted infections; nonoxynol-9 does not provide reliable STI prevention and can irritate genital mucosa. Greater efficacy than male condoms - The contraceptive sponge has a relatively higher typical-use failure rate than the male condom, particularly among parous women. - Male condoms are generally more effective with typical use and additionally provide protection against many sexually transmitted infections, which the sponge does not. Insertion immediately after coitus - The sponge is intended for pre-coital insertion, allowing it to be positioned before intercourse and used for multiple acts. - Immediate post-coital insertion would not provide the required pre-intercourse spermicide and sperm-trapping action, so this is not its characteristic use.

Flashcards: Reproductive Considerations for Transgender Patients

  1. 1. _____ is used to treat _____ due to anovulation (e.g. PCOS)

    Show answer

    Clomiphene · infertility

  2. 2. Spinnbarkeit or the thread test is associated with  effect.

    Show answer

    Estrogen::hormone

  3. 3. Oral contraceptive pills (OCP) protect against cancer.

    Show answer

    ovarian

  4. 4. is the fertilization of two ova released in different menstrual cycles

    Show answer

    Superfetation

  5. 5. Infertility is defined as lack of conception despite months of regular unprotected intercourse in women aged < 35 years.

    Show answer

    12

  6. 6. In women, decreased levels of sex hormone-binding globulin (SHBG) causes _____ due to _____ free testosterone

    Show answer

    hirsutism · increased

  7. 7. If beta-HCG values are less than 1500 IU/L, and there is decreasing trend in levels (between day 1 and day 3), it suggests

    Show answer

    abortion

  8. 8. Essure blocks the fallopian tube permanently but requires a period of  months to be effective

    Show answer

    3

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF